Category Archives: Stem Cell Transplant

Scientists at NUI Galway may be able to reduce the rejection rate of corneal transplant operations, meaning the number of people rendered blind from corneal eye disease may decrease. The research, which uses stem cells, could lead to more patients holding onto their sight, if the technique can be replicated in humans. Corneal eye disease is the fourth most common cause of blindness, affecting ten million people worldwide. Corneal transplants are the most common form of treatment for the condition, and involve the replacement of the damaged cornea with healthy tissue from an organ donor. Although 100,000 people undergo corneal transplants each year, the procedure suffers from a high rejection rate of 30%. However, researchers at the REMEDI regenerative medicine institute at NUI Galway have developed a new system which could reduce rejection rates to as low as 10%. The lab based study, details of which are published in the American Journal of Transplantation, involves the use of a type of stem cell grown from the bone marrow of adult donors, which when administered adjusts the immune system's balance, reducing rejection. A follow up 6m EU funded study is now under way to examine the issue more closely, and will … Continue reading →

Adult Stem Cell Success - CIDP: Bryan Hinkle Just over a year ago, Bryan Hinkle had all but given up. C.I.D.P. had beaten him down and he was literally waiting for the end. But an adult stem cell transplant gave him new life and a new... By: StemCellFactsNow … Continue reading →

By Amy Norton HealthDay Reporter WEDNESDAY, Sept. 3, 2014 (HealthDay News) -- A cancer drug that targets the immune system may help improve the outlook for older adults with multiple myeloma, though a stem cell transplant remains the standard of care for relatively younger patients. Those are some of the findings from two studies in the Sept. 4 issue of the New England Journal of Medicine. Multiple myeloma is a cancer that begins in certain white blood cells. In the United States, it accounts for about 1 percent of cancers, and for those who develop it, it's often deadly. About 45 percent of Americans with the disease are still alive five years after diagnosis, according to the U.S. National Cancer Institute. For years, the standard treatment -- at least for patients younger than 65 -- has involved removing blood-forming stem cells from the patient's bone marrow or bloodstream, then using high-dose chemo to kill off the myeloma cells. Afterward, the stored stem cells are infused back into the patient, where they aid in recovery. That extends people's cancer remission, but it's not a cure, said Dr. David Avigan, who treats myeloma patients at Beth Israel Deaconess Medical Center in Boston. … Continue reading →

Scientists at NUI Galway may be able to reduce the rejection rate of corneal transplant operations, meaning the number of people rendered blind from corneal eye disease may decrease. The research, which uses stem cells, could lead to more patients holding onto their sight, if the technique can be replicated in humans. Corneal eye disease is the fourth most common cause of blindness, affecting 10 million people worldwide. Corneal transplants are the most common form of treatment for the condition, and involve the replacement of the damaged cornea with healthy tissue from an organ donor. Although 100,000 people undergo corneal transplants each year, the procedure suffers from a high rejection rate of 30%. However, researchers at the REMEDI regenerative medicine institute at NUI Galway have developed a new system which could reduce rejection rates to as low as 10%. The lab based study, details of which are published in the American Journal of Transplantation, involves the use of a type of stem cell grown from the bone marrow of adult donors, which when administered adjusts the immune system's balance, reducing rejection. A follow up 6m EU funded study is now underway to examine the issue more closely, and will involve … Continue reading →

FATHER-OF-TWO Johnny Pearson's life was saved when a stranger donated stem cells. The pair became friends and raised thousands for charity by running in the London Marathon together. By health reporter Kate Liptrot. EARLIER this year Johnny Pearson became the first person to run the London Marathon alongside the unrelated stem cell donor who had saved his life. The 44-year-old was diagnosed with acute myeloid leukaemia in 2010 and often thought of the stranger had been who allowed him to have a bone marrow transplant two years later. Earlier this year he met 23-year-old donor Sean Hagan for the first time - and weeks after meeting they ran the London marathon to raise money and awareness for the Anthony Nolan Bone Marrow Trust. The wine trader from Thorpe Underwood was first diagnosed with the aggressive form of cancer in September 2010 when he had been to see the doctor after feeling slightly under the weather and the doctor had done a blood test just to make sure. He was driving home from work when he received a phone call from the doctor to say that something was seriously wrong and he needed to turn around and go to York Hospital. … Continue reading →

Saanvi Ortho Stem Cell Transplant Clinic Patient's Testimonial of Dr. S.S. Tripathi owner of Saanvi Ortho Stem Cell Transplant Clinic. By: Smartwebeasy Consultants … Continue reading →

Benefit helps pay for stem cell transplant for local teen WHITEWATER TOWNSHIP, Ohio (WKRC) -- Supporters came together for a woman battling a rare disease. Local 12 News first introduced viewers to Kayla Pounds. The... By: LOCAL 12 … Continue reading →

VILLA GROVE A benefit dinner to help with upcoming expenses for a stem cell transplant for Tom Ryan of Villa Grove will be held from 4-7 p.m. Sept. 13 at Villa Grove United Methodist Church, 302 Second St., Villa Grove. Ryan, who was born with a rare, inherited immunodeficiency disorder called WHIM syndrome, is facing cancer for a fifth time and will be undergoing a stem cell transplant in Chicago or Maryland. Ryan will have to live in the area where the transplant is being done for several months, and the money is being raised to help cover medical bills, transportation costs and living expenses for him and his wife, Staci. The benefit will include a fried chicken dinner prepared by Betty Hancock, a silent auction, a "Hammering out Cancer" T-shirt sale and music. The dinner will include fried chicken with mashed potatoes and gravy, green beans, coleslaw, drinks and dessert. Admission will be a free-will donation. More: Benefit to help pay for stem-cell transplant … Continue reading →

Improving Overall Survival after Stem Cell Transplant Improving Overall Survival after Stem Cell Transplant. By: The Oncologist Journal … Continue reading →

PUBLIC RELEASE DATE: 25-Aug-2014 Contact: Paddy Moore padmoore@ohri.ca 613-737-8899 x73687 The JAMA Network Journals Bottom Line: Two female patients achieved clinical remission from the rare, debilitating neurological disease called stiff person syndrome (SPS, which can be marked by a "tin soldier" gait) after an autologous (from your own body) stem cell transplant that eventually allowed them to return to work and regain their previous functioning. Author: Sheilagh Sanders, M.D., of the University of Ottawa, Canada, and colleagues. Background: SPS is a disease characterized by stiffness of the skeletal muscles, painful muscle spasms and, in severe cases, the disease can prevent movement and walking. Autologous hematopoietic stem cell transplantation (auto-HSCT) has been used to successfully treat patients with autoimmune diseases such as multiple sclerosis and scleroderma, which are resistant to more conventional treatment. A regimen of high-dose chemotherapy and antilymphocyte antibodies rid the body of diseased immune cells (immunoablation) before the immune system is regenerated with auto-HSCs. About the Care Report: The Ottawa Hospital Blood and Marrow Transplant Program performed immunoablation and auto-HSCT on the two women with severe SPS based on a regimen used for multiple sclerosis. Results: One of the women was diagnosed in 2005 at age 48 after … Continue reading →